Evidence map›Paper›PMID 22027478›Full record

ArticleGut2012

Lactobacillus probiotic protects intestinal epithelium from radiation injury in a TLR-2/cyclo-oxygenase-2-dependent manner.

Matthew A Ciorba, Terrence E Riehl, M Suprada Rao, Clara Moon, Xueping Ee, Gerardo M Nava, Monica R Walker, Jeffrey M Marinshaw, Thaddeus S Stappenbeck, William F Stenson

2 registry-linked trialsOpen access · hybridAbstract read
In one paragraph

Article in Gut, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 148 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
148citing papers in PubMed, 1 pooled it
7.0field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01790035 phase1terminatednot on this mapstarted 2014, after this paper: background citation

A Phase I and Randomized Controlled Phase II Trial of the Probiotic LGG for Prevention of Side Effects in Patients Undergoing Chemoradiation for Gastrointestinal Cancer

TypeinterventionalSponsorWashington University School of MedicineRan2014 to 2021Enrolled23ConditionsGastrointestinal NeoplasmsArmsLGG, Placebo
NCT03574051 early_phase1unknown statusnot on this mapstarted 2018, after this paper: background citation

Distinct Shifts in the Microbiota Are Associated With Iodine-131 Therapy and Hypothyroidism

TypeinterventionalSponsorFirst Affiliated Hospital of Harbin Medical UniversityRan2018 to 2022Enrolled30ConditionsMicrobiotaArmsProbiotic
3 · Its place in the literature

Who cites it

148 citing papers in PubMed, 1 synthesis or guideline pooled it, 280 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Review
  14. Review
  15. Review
  16. Review
  17. Food science & nutrition · 2025
    Article
  18. Review
  19. Review
  20. Review

88 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 2 countries.

Matthew A CiorbaDivision of Gastroenterology, Washington University Saint Louis, 660 South Euclid Avenue, Box 8124, Saint Louis, MO 63110, USA. MCiorba@dom.wustl.edu
Terrence E Riehl
M Suprada Rao
Clara Moon
Xueping Ee
Gerardo M Nava
Monica R Walker
Jeffrey M Marinshaw
Thaddeus S Stappenbeck
William F Stenson
Washington University in St. Louis · USUniversity Gastroenterology · USCenter for Genomic Science · IT

Funding

Washington University DDRCC Supplemental Equipment RequestP30DK052574 · NIDDK · WASHINGTON UNIVERSITY · PI Nicholas O. Davidson · 2000 to 2026
$30.8M
Training Program in Pediatric EndocrinologyT32DK007161 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Brian J Feldman, STEPHEN E GITELMAN · 1986 to 2026
$6.2M
PROSTAGLANDINS IN EPITHELIAL INJURYR01DK055753 · NIDDK · WASHINGTON UNIVERSITY · PI STENSON, WILLIAM F. · 1999 to 2013
$3.8M
Mediators of Inflammation in Intestinal InjuryR37DK033165 · NIDDK · WASHINGTON UNIVERSITY · PI STENSON, WILLIAM F. · 2007 to 2016
$3.5M
RESPONSES OF INTESTINAL STEM CELLS TO EPITHELIAL INJURYR01DK071619 · NIDDK · WASHINGTON UNIVERSITY · PI STAPPENBECK, THADDEUS S · 2008 to 2017
$3.2M
MEDIATORS OF INFLAMMATION IN INFLAMMATORY BOWEL DISEASER01DK033165 · NIDDK · WASHINGTON UNIVERSITY · PI STENSON, WILLIAM F. · 1986 to 2006
$1.9M
Indoleamine 2,3 Dioxygenase in Colitis Associated CancerK08DK089016 · NIDDK · WASHINGTON UNIVERSITY · PI CIORBA, MATTHEW AARON · 2010 to 2014
$712k
NCRR NIH HHS L30 RR030244NIDDK NIH HHS DK071619NIDDK NIH HHS DK07161-90251NIDDK NIH HHS DK089016NIDDK NIH HHS DK33165NIDDK NIH HHS DK55753NIDDK NIH HHS K08 DK089016NIDDK NIH HHS P30 DK052574NIDDK NIH HHS P30-DK52574NIDDK NIH HHS R01 DK033165NIDDK NIH HHS R01 DK055753NIDDK NIH HHS R01 DK071619NIDDK NIH HHS R37 DK033165
6 · The paper itself

Abstract

backgroundThe small intestinal epithelium is highly sensitive to radiation and is a major site of injury during radiation therapy and environmental overexposure.

objectiveTo examine probiotic bacteria as potential radioprotective agents in the intestine.

methods8-week-old C57BL/6 wild-type or knockout mice were administered probiotic by gavage for 3 days before 12 Gy whole body radiation. The intestine was evaluated for cell-positional apoptosis (6 h) and crypt survival (84 h).

resultsGavage of 5×10⁷ Lactobacillus rhamnosus GG (LGG) improved crypt survival about twofold (p<0.01); the effect was observed when administered before, but not after, radiation. Conditioned medium (CM) from LGG improved crypt survival (1.95-fold, p<0.01), and both LGG and LGG-CM reduced epithelial apoptosis particularly at the crypt base (33% to 18%, p<0.01). LGG was detected in the distal ileal contents after the gavage cycle, but did not lead to a detectable shift in bacterial family composition. The reduction in epithelial apoptosis and improved crypt survival offered by LGG was lost in MyD88⁻/⁻, TLR-2⁻/⁻ and cyclo-oxygenase-2⁻/⁻ (COX-2) mice but not TLR-4⁻/⁻ mice. LGG administration did not lead to increased jejunal COX-2 mRNA or prostaglandin E2 levels or a change in number of COX-2-expressing cells. However, a location shift was observed in constitutively COX-2-expressing cells of the lamina propria from the villi to a position near the crypt base (villi to crypt ratio 80:20 for control and 62:38 for LGG; p<0.001). Co-staining revealed these COX-2-expressing small intestinal lamina propria cells to be mesenchymal stem cells.

conclusionsLGG or its CM reduce radiation-induced epithelial injury and improve crypt survival. A TLR-2/MyD88 signalling mechanism leading to repositioning of constitutive COX-2-expressing mesenchymal stem cells to the crypt base is invoked.

Indexed as

AnimalsApoptosisCyclooxygenase 2FemaleIntestinal MucosaLacticaseibacillus rhamnosusMiceMice, Inbred C57BLMice, KnockoutMyeloid Differentiation Factor 88ProbioticsRadiation Injuries, ExperimentalReverse Transcriptase Polymerase Chain ReactionToll-Like Receptor 2Whole-Body IrradiationCyclooxygenase 2Myd88 protein, mouseMyeloid Differentiation Factor 88Ptgs2 protein, mouseTlr2 protein, mouseToll-Like Receptor 2

Identifiers

PMID22027478
PMCPMC3345937
OpenAlexW2038859574

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.